SCHEMBL648802

SCHEMBL648802

N#Cc1ccccc1CN1CC(NS(=O)(=O)c2ccccc2)Cc2cc(Cl)ccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 4/20 0.57
FNTB P49356 4/20 0.57
HDAC8 Q9BY41 1/20 0.41
TBXA2R P21731 3/20 0.40
HTT P42858 1/20 0.39
CTSB P07858 3/20 0.39
CTSK P43235 3/20 0.39
UCHL1 P09936 2/20 0.39
CTSS P25774 2/20 0.39
CTSC P53634 2/20 0.39
USP30 Q70CQ3 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
THRB P10828 1/20 0.39
CTSL P07711 1/20 0.39
BRD4 O60885 1/20 0.38
HTR1A P08908 2/20 0.37
HTR7 P34969 2/20 0.37
CYP3A4 P08684 1/20 0.37
DPP4 P27487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651258 0.85 FNTA (0.55) FNTAFNTBHDAC8TBXA2RHTT
SCHEMBL648914 0.84 FNTA (0.49) FNTAFNTBHDAC8HTTTHRB
SCHEMBL651578 0.84 FNTA (0.62) FNTAFNTBHDAC8HTTSIRT2
SCHEMBL652553 0.83 FNTA (0.66) FNTAFNTBCTSBCTSKUCHL1
SCHEMBL652345 0.83 FNTA (0.49) FNTAFNTBHDAC8TBXA2RHTT
SCHEMBL652554 0.83 FNTA (0.66) FNTAFNTBCTSBCTSKUCHL1
SCHEMBL650207 0.83 FNTA (0.61) FNTAFNTBHDAC8HTTSIRT2
SCHEMBL651452 0.82 FNTA (0.67) FNTAFNTBHDAC8TBXA2RHTT
SCHEMBL651451 0.82 FNTA (0.67) FNTAFNTBHDAC8TBXA2RHTT
SCHEMBL653037 0.81 FNTA (0.49) FNTAFNTBHDAC8TBXA2RHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884113-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-08 US claimed
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2008-08-14 US claimed
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2005-01-20 US claimed
US-8119808-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-21 US disclosed
US-20110104315-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2011-05-05 US disclosed
US-7884113-B2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-08 US disclosed
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2008-08-14 US disclosed
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110104315-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885HDAC8 2618/4885
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885HDAC8 2618/4885
US-20080194625-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CNR2, CNR1, OPRL1 FNTA 1368/4885FNTB 2071/4885HDAC8 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.